ALSO NOTED: AmerisourceBergen buys Canadian wholesaler; AlgoRx touts Phase III pain study; Newron adds venture capital; and muc

> Drug wholesale giant AmerisourceBergen said it has acquired Trent Drugs, Canada's largest drug wholesaler, for $83 million. Report

> AlgoRx said that a late-stage study of ALGRX 3268 successfully reduced the pain children experienced from needle pricks. Article

> Italy's Newron Pharmaceuticals has added €7 million to its second round of venture capital, which closed with a total of €30 million. Release

> GenVec has received $9.9 million in new funding for its work in HIV vaccine development. Release

And Finally… The death toll from a mysterious respiratory illness in a Toronto nursing home has hit 10, but health officials say that it appears that the outbreak has peaked. SARS, avian flu and other viruses have already been ruled out without being able to find the culprit. Article

Suggested Articles

IMV’s lead immunotherapy stopped ovarian cancer from getting worse in more than three-quarters of patients in a small phase 2 study.

The money will fund early-phase development of a CD47x4-1BB bispecific that Kahr plans to test with Roche’s checkpoint inhibitor Tecentriq.

Bicycle will apply its discovery platform to multiple targets, putting itself in a position to pull in up to $1.7 billion in milestones.